
Award · 18 September 2026TheranautilusMagnetically controlled nanorobot medical technologytheranautilus.com ↗
Theranautilus wins Top Innovator at ET Startup Awards
By Abha Lohia · Editor ·
earlyFounded 2020
- Theranautilus develops magnetically controlled nanorobots designed for targeted drug delivery, diagnostics, and medical treatments
- The company won the Top Innovator award at the 2026 ET Startup Awards and is preparing for human dental trials
- The startup plans to commercialize its oral health solution within two years and its oncology technology within five years
What happened
- Theranautilus received the Top Innovator title at the ET Startup Awards 2026.
- The company will begin human trials for its dental nanorobot technology between November and December 2026.
- The initial phase of the trial will involve approximately 30 patients.
- A larger multicentric trial involving 300 patients will follow the first phase.
- Human testing follows successful mice trials and official CDSCO (Central Drugs Standard Control Organisation) permission.
- The company aims to launch its oral health solution commercially within two years.
Why it matters
- The startup was previously recognized as one of India's Top 10 innovative startups by the government.
- It has received several honors including the Presidential National Award and the Tata Transformation Prize.
- The company's technology has been showcased to international leaders and the Prime Minister of India.
The business
- The company builds magnetically controlled nanorobots for medical applications.
- Its core pillars are Reach, Diagnose, and Treat at the microscale level.
- The lead product for oncology is named CalBot.
- Dental applications include treating dentin hypersensitivity and managing biofilms.
- Oncology applications focus on the brain and peritoneal cavity.
- The technology is currently at TRL-5 (Technology Readiness Level 5).
The founders
PS
Peddi Shanmukh Srinivas
Cofounder & CEO- Serves as the Chief Executive Officer of the company.
- Leads the strategic development of the nanorobotics platform.
In numbers
1 Billion+Addressable patients · 2026
What happens next
- Commercialize oral health technology within two years.
- Commercialize oncology technology within four to five years.
Words to know
- CDSCO
- The national regulatory body for Indian pharmaceuticals and medical devices.
- Multicentric trial
- A clinical trial conducted at more than one medical center or site.
- TRL-5
- Technology Readiness Level 5 indicates the technology has been validated in a relevant environment.
The numbers around it
Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 18 September 2026 →
Is this Theranautilus? Get your “Featured on StopDown” badge →